Profile
W.
Bruce Rowlands served as Chairman of XORTX Therapeutics, Inc. from 2018 to 2021.
Served as Director at Talisker Resources Ltd. in 2018.
Served as Director at XORTX Pharma Corp.
Served as Director & Vice President at Dominick & Dominick Securities, Inc. from 1999 to 2003.
Served as Independent Director at A-Labs Capital II Corp.
from 2018 to 2023.
Served as Senior Vice President-Planning & Public Affairs at Aptose Biosciences, Inc. from 2003 to 2005.
Former jobs include Chairman at XORTX Therapeutics, Inc., Director at Talisker Resources Ltd., Director at XORTX Pharma Corp., Director & Vice President at Dominick & Dominick Securities, Inc., Independent Director at A-Labs Capital II Corp., and Senior Vice President-Planning & Public Affairs at Aptose Biosciences, Inc.
Former positions of W. Rowlands
| Companies | Position | End |
|---|---|---|
| A-LABS CAPITAL II CORP. | Director/Board Member | 2023-06-30 |
| XORTX THERAPEUTICS INC. | Chairman | 2021-12-19 |
| TALISKER RESOURCES LTD. | Chief Executive Officer | 2018-03-14 |
| APTOSE BIOSCIENCES INC. | Public Communications Contact | 2004-12-31 |
Dominick & Dominick Securities, Inc. | Director/Board Member | 2002-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Aptose Biosciences, Inc.
Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Talisker Resources Ltd.
Talisker Resources Ltd. Precious MetalsNon-Energy Minerals Engages exploration and development gold and silver project | Non-Energy Minerals |
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology Produces biopharmaceutical products | Health Technology |
Dominick & Dominick Securities, Inc. | |
XORTX Therapeutics, Inc.
XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
A-Labs Capital II Corp.
A-Labs Capital II Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
- Stock Market
- Insiders
- W. Rowlands
















